Chiesi Farmaceutici S.p.a.

Annamaria Soliani Raschini

Fausto Pivetti

Marisa Pertile

Monica Bocchi

Franco Sartor

Akif Emre Türeli

Eva Marie Prinz

Akif Emre Tureli

Physically and chemically stable pharmaceutical formulations in the form of an aqueous suspension comprising a reconstituted pulmonary surfactant are useful for the prophylaxis and/or treatment of respiratory distress syndrome (RDS) and other respiratory disorders.

Stable pharmaceutical formulation comprising a reconstituted pulmonary surfactant composition

Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.

Melatonin-based formulations for parenteral administration

Reconstituted pulmonary surfactants comprising a lipid carrier, a combination of polypeptide analog of the native surfactant protein SP-C with a particular polypeptide analog of the native surfactant protein SP-B may be used for the treatment or prophylaxis of RDS and other respiratory disorders.

Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)

Growing community of inventors

Parma, Italy

Annamaria Soliani Raschini